US STOCKS-Wall St opens higher on M&A, Citi earnings (Reporting by Chuck Mikolajczak; Editing by Chizu Nomiyama and Nick Zieminski) Link this "It's very important to see this reversal now in the economy heading into the second quarter," said Anastasia Amoroso, Global Market Strategist with J.P. Mylan shares advanced 1.9 percent to $51.17 before the opening bell. Abbott shares rose 0.5 percent to $41.52. Earnings season will pick up speed this week, with 59 S&P 500 components scheduled to report.
3
Embed
US STOCKS-Wall St opens higher on M&A, Citi earnings
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
8/12/2019 US STOCKS-Wall St opens higher on M&A, Citi earnings
S&P 500 profits are seen growing 6.2 percent in the second quarter, according to Thomson Reuters
data, down from the 8.4 percent growth forecast at the start of April. Morgan Funds, in New York.
URS shares jumped 9.1 percent to $56.73 and AECOM gained 3.8 percent to $32.97. The S&P
financial index gained 0.8 percent.
* Citigroup up after earnings, settlement
The Dow Jones industrial average rose 126.83 points or 0.75 percent, to 17,070.64, the S&P 500
gained 10.68 points or 0.54 percent, to 1,978.25 and the Nasdaq Composite added 25.16 points or
0.57 percent, to 4,440.65.
Email
Mon Jul 14, 2014 10:25am EDT
* Shire to accept Abbvie takeover offer
Engineering design firm AECOM Technology Corp on Sunday said it would pay about $4 billion to
acquire engineering and construction services firm URS Corp. In order to justify current stock
prices, analysts are looking to earnings to confirm the economy recovered in the second quarter
from the impact of a harsh winter.
Citigroup Inc shares rose 3.9 percent to $48.83 as one of the top boosts to the S&P 500 after it
posted second-quarter earnings and agreed to pay $7 billion to settle a U.S. stocks rose on Monday,
buoyed by the latest flurry of merger activity and earnings from Citigroup, putting the S&P 500 on
pace to climb for a second straight session.
London-listed drugmaker Shire Plc said it was ready to recommend to agree to an increased 31billion pounds ($53 billion) takeover offer from Abbvie Inc, ending a long-running courtship largely
motivated by tax rates. U.S.-listed shares of Shire rose 1.9 percent to $253.71 while Abbvie shed 0.9